MEK 1 inhibition and bleeding in hereditary haemorrhagic telangiectasia.

导出 LinkOut

翻译打印收藏纠错

作者： Claire L,Shovlin ^[1] ; Dilip,Patel ^[2] ; Adrianna,Bielowka ^[3] ; Jonathan A,Ledermann ^[1] ; Atieh,Modarresi ^[2] ; Genomics England Research Consortium ^[1] ; Maria E,Bernabeu-Herrero ^[2] ; Micheala A,Aldred ^[4] ; Ali,Alsafi ^[1]

作者单位： National Heart and Lung Institute, Imperial College London, London, UK. ^[1] NIHR Imperial Biomedical Research Centre, London, UK. ^[2] Imperial College Healthcare NHS Trust, London, UK. ^[3] Department of Oncology, University College London Cancer Institute, London, UK. ^[4] Genomics England, London, UK. ^[5] Indiana University School of Medicine, Indianapolis, Indiana, USA. ^[6]

主题词人类(Humans);毛细血管扩张, 遗传性出血性(Telangiectasia, Hereditary Hemorrhagic);出血(Hemorrhage);治疗结果(Treatment Outcome);丝裂原激活蛋白激酶激酶类(Mitogen-Activated Protein Kinase Kinases);鼻出血(Epistaxis)

DOI 10.1111/bjh.19167

PMID 37872650

发布时间 2024-03-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交